AccuVein
Latest round
- Series B
Last raised
- Oct 2011
Total raised
- $23M
Investors
- 2
About AccuVein
AccuVein Inc. provides advanced vein visualization solutions that enhance vascular access procedures, improving efficiency and effectiveness for healthcare professionals.AccuVein Inc. was founded in 2006 in New York, US, focusing on vein visualization technology.00 mn.AccuVein, Inc. specializes in advanced vein visualization solutions designed to enhance the efficiency and effectiveness of vascular access procedures. Their core product, the AccuVein device, utilizes near-infrared (NIR) technology to illuminate veins, valves, and bifurcations that are typically not visible to the naked eye. This innovation aids healthcare professionals in making informed decisions regarding needle placement, thereby improving first-attempt success rates for peripheral intravenous (PIV) catheter insertions. The devices are employed primarily in acute care settings, non-acute care facilities, and aesthetic practices, effectively serving a diverse clientele that includes hospitals, outpatient clinics, and specialized treatment centers across North America, Europe, and Asia.AccuVein generates revenue through direct sales of its flagship vein visualization devices and associated accessories to healthcare providers, including hospitals and outpatient clinics. The company's transactional structure consists of B2B sales, focusing on building long-term relationships with healthcare organizations that integrate AccuVein’s technology into their vascular access protocols. These transactions typically involve one-time purchases of the devices, as well as recurring sales of consumables or accessories necessary for the operation of the vein visualization systems. Pricing plans reflect the value of the technology in improving procedural efficiency and patient outcomes, aligning with industry standards for medical device pricing.AccuVein plans to launch new products designed to further improve vein visualization technology, with specific release dates yet to be announced. The company is looking to expand into new markets across North America, Europe, and Asia by 2024.
Who invested in AccuVein
2 investors across 2 rounds
See all investors in AccuVein
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AccuVein
Who invested in AccuVein?
AccuVein has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AccuVein raised?
AccuVein has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AccuVein last raise money?
AccuVein's most recent round on record is a Series B, in Oct 2011.
What does AccuVein do?
AccuVein is a medical devices & equipment company.
Where is AccuVein headquartered?
AccuVein is headquartered in New York, US.
Which VCs invest in companies like AccuVein?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at AccuVein's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like AccuVein? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.